title: Gabapentin-Induced myoclonus: case report.
authors.forename: Fahrettin
authors.initials: F
authors.lastname: Ege
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Koçak
authors.forename: Ayse P
authors.initials: AP
authors.lastname: Titiz
authors.forename: Semra Mungan
authors.initials: SM
authors.lastname: Oztürk
authors.forename: Serefnur
authors.initials: S
authors.lastname: Oztürk
authors.forename: Senay
authors.initials: S
authors.lastname: Ozbakir
mesh_terms: D000369:Aged, 80 and over; D000588:Amines / Q000009:adverse effects*; D000978:Antiparkinson Agents / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects*; D000077206:Gabapentin; D006801:Humans; D008297:Male; D009207:Myoclonus / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects*
chemical_list: D000588:Amines; D000978:Antiparkinson Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin